BlueDot, a disease containment technology spinout set up by St Michael’s Hospital and Mars Innovation, has secured series A capital.

BlueDot, a Canada-based disease containment technology developer spun out in partnership with multi-institution commercialisation firm Mars Innovation, has attracted C$9.2m ($6.9m) in series A funding, BetaKit reported yesterday. Insurance co-operative The Co-operators and Canadian government-owned venture arm BDC Capital co-led the round, investing through their respective funds Insurtech and Women in Technology Venture Fund. Founded…

The rest of this content is only accessible to University Venturing: News, Data, and Events - Global University Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.